A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.
作者信息
Joseph Laure, De Luna Gonzalo, Bernit Emmanuelle, Cougoul Pierre, Santin Aline, Faucher Benoit, Habibi Anoosha, Garou Alain, Loko Gylna, Mattioni Sarah, Manceau Sandra, Arlet Jean Benoit, Lionnet François
机构信息
Biotherapy Department, French National Sickle Cell Disease Referral Center, Clinical Investigation Center, Hopital Necker, Labex GR-Ex, Assistance-Publique Hopitaux de Paris, Paris.
Unite des maladies genetiques du globule rouge and Etablissement Francais du Sang, Hopital Henri Mondor, Assistance-Publique Hopitaux de Paris, Creteil.
出版信息
Haematologica. 2024 May 1;109(5):1562-1565. doi: 10.3324/haematol.2023.283300.
Abstract
摘要
相似文献
1
A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.一项针对28名患有镰状细胞病和新冠肺炎的孕妇的研究：孕产妇和胎儿发病率升高。
Haematologica. 2024 May 1;109(5):1562-1565. doi: 10.3324/haematol.2023.283300.
2
Sickle cell disease, pregnancy, and COVID-19 in France: .法国的镰状细胞病、妊娠与新型冠状病毒肺炎
Haematologica. 2024 May 1;109(5):1328-1330. doi: 10.3324/haematol.2023.284457.
3
Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy.病例报告：三位镰状血红蛋白病患者的产科和与 COVID-19 相关的发病率和死亡率。
Am J Trop Med Hyg. 2024 Apr 23;110(6):1198-1200. doi: 10.4269/ajtmh.23-0761. Print 2024 Jun 5.
4
Sickle cell disease and COVID-19 in pregnant women.镰状细胞病与孕妇 COVID-19
J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102328. doi: 10.1016/j.jogoh.2022.102328. Epub 2022 Jan 29.
5
An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.分析 38 例 COVID-19 孕妇、其新生儿和 SARS-CoV-2 的母婴传播：冠状病毒感染与妊娠结局。
Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805. doi: 10.5858/arpa.2020-0901-SA.
6
Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study.镰状细胞贫血的高复杂性产科人群中险些发生事件的标准描述：一项观察性研究。
J Matern Fetal Neonatal Med. 2020 Mar;33(6):941-946. doi: 10.1080/14767058.2018.1510912. Epub 2018 Sep 19.
7
Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions.镰状细胞病患者的妊娠：接受预防性部分换血治疗的人群中的母婴结局。
Eur J Obstet Gynecol Reprod Biol. 2010 Oct;152(2):138-42. doi: 10.1016/j.ejogrb.2010.05.022. Epub 2010 Sep 16.
8
Sickle trait and its association with birthweight and urinary tract infections in pregnancy.镰状细胞性状及其与出生体重和孕期尿路感染的关联。
Int J Gynaecol Obstet. 1990 Sep;33(1):19-21. doi: 10.1016/0020-7292(90)90649-6.
9
[Asymptomatic bacteriuria in the Congolese pregnant woman. Preliminary data on its incidence and relation to the sickle trait].[刚果孕妇的无症状菌尿症。关于其发病率及与镰状细胞性状关系的初步数据]
Ann Soc Belges Med Trop Parasitol Mycol. 1967;47(6):413-24.
10
Maternal and perinatal outcome of women with sickle cell disease of a tribal population in Central India.印度中部部落人群镰状细胞病女性的孕产妇及围产期结局
Hemoglobin. 2014;38(2):91-4. doi: 10.3109/03630269.2013.869501. Epub 2014 Jan 13.
引用本文的文献
1
Sickle cell disease, pregnancy, and COVID-19 in France: .法国的镰状细胞病、妊娠与新型冠状病毒肺炎
Haematologica. 2024 May 1;109(5):1328-1330. doi: 10.3324/haematol.2023.284457.
本文引用的文献
1
Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.213 例镰状细胞病成年患者中 2019 冠状病毒病疫苗的安全性。
Br J Haematol. 2023 Mar;200(5):563-567. doi: 10.1111/bjh.18547. Epub 2022 Nov 10.
2
[SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].[严重急性呼吸综合征冠状病毒2型疫苗在孕妇中的接受情况——一项横断面调查]
Gynecol Obstet Fertil Senol. 2022 Nov;50(11):712-720. doi: 10.1016/j.gofs.2022.07.004. Epub 2022 Jul 29.
3
Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study.COVID-19 孕妇及新生儿结局：PAN-COVID 研究。
Eur J Obstet Gynecol Reprod Biol. 2022 Sep;276:161-167. doi: 10.1016/j.ejogrb.2022.07.010. Epub 2022 Jul 19.
4
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒（SARS-CoV-2）个体的症状流行率、持续时间及住院风险：来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
5
Sickle cell disease and COVID-19 in pregnant women.镰状细胞病与孕妇 COVID-19
J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102328. doi: 10.1016/j.jogoh.2022.102328. Epub 2022 Jan 29.
6
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.住院镰状细胞病患者发生重症 COVID-19 的危险因素：法国 319 例患者的研究。
Am J Hematol. 2022 Mar 1;97(3):E86-E91. doi: 10.1002/ajh.26432. Epub 2021 Dec 18.
7
Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.围生期结局在镰状细胞病女性患者中的表现：来自英国伦敦的一项匹配队列研究。
Br J Haematol. 2022 Feb;196(4):1069-1075. doi: 10.1111/bjh.17983. Epub 2021 Dec 8.
8
An update on COVID-19 and pregnancy.关于 COVID-19 与妊娠的最新资讯。
Am J Obstet Gynecol. 2022 Feb;226(2):177-186. doi: 10.1016/j.ajog.2021.08.054. Epub 2021 Sep 14.
9
Severity of illness by pregnancy status among laboratory-confirmed SARS-CoV-2 infections occurring in reproductive-aged women in Colombia.哥伦比亚生育年龄段女性中实验室确诊的 SARS-CoV-2 感染的妊娠状态与疾病严重程度的关系。
Paediatr Perinat Epidemiol. 2022 Jul;36(4):456-465. doi: 10.1111/ppe.12808. Epub 2021 Sep 1.
10
Maternal outcomes and risk factors for COVID-19 severity among pregnant women.孕产妇感染 COVID-19 严重程度的结局和危险因素。
Sci Rep. 2021 Jul 6;11(1):13898. doi: 10.1038/s41598-021-92357-y.
Zotero 插件